Claudia K. Derian

Papers

1

Total Citations

33

H-Index

1

About

Claudia K. Derian is a distinguished researcher whose work has significantly advanced the field of functional genomics and target validation. Her key research areas include high-throughput screening technologies, particularly siRNA-based approaches, and their application in drug discovery. Derian's major contribution lies in pioneering high-throughput siRNA methodologies that enable rapid, systematic functional validation of potential therapeutic targets. Her seminal 2004 paper on this topic has garnered 33 citations, establishing a foundational framework for researchers seeking to efficiently assess gene function in disease contexts. This work has been instrumental in bridging the gap between genomic discoveries and clinical applications, allowing for more precise identification of drug targets. Derian's impact extends beyond her own publications, as her methodologies have been widely adopted in both academic and pharmaceutical settings, accelerating the pace of target discovery and validation. Her achievements reflect a career dedicated to translating genomic insights into actionable therapeutic strategies, making her a respected figure in the field of functional genomics and drug development.

Research Focus

Key Achievements

1
H-Index
1
Papers
33
Total Citations
33
Avg Citations/Paper
🏆 Most Cited Paper
High-Throughput siRNA-Based Functional Target Validation
33 citations · 2004
📈 Most Prolific Year: 2004 (1 Papers)
🤝 Key Collaborators: 9

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago